BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37655555)

  • 1. Homeobox-D 1 and FTO form a transcriptional-epigenetic feedback loop to promote head and neck cancer proliferation.
    Zhang C; Xie L; Lin Z
    Cell Biol Int; 2023 Dec; 47(12):1987-1998. PubMed ID: 37655555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer analysis reveals the pro-oncogenic role of N6-methyladenosine (m6A)-regulated NTMT1 in head and neck squamous cell carcinoma.
    Zhao C; Yu M; Li Y
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23603. PubMed ID: 38014887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma.
    Chen X; Liu Y; Sun D; Sun R; Wang X; Li M; Song N; Ying J; Guo T; Jiang Y
    Cancer Sci; 2022 Jun; 113(6):2071-2084. PubMed ID: 35403343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
    Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of HOX genes promotes cell migration and proliferation in head and neck squamous cell carcinoma.
    Aguiar GM; Ramão A; Plaça JR; Simões SC; Scaraboto NV; Freitas-Castro F; Cardoso C; Sousa JF; Silva WA
    Tumour Biol; 2021; 43(1):263-278. PubMed ID: 34633333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
    Hu Y; Chen J; Liu M; Feng Q; Peng H
    Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma.
    Wang F; Liao Y; Zhang M; Zhu Y; Wang W; Cai H; Liang J; Song F; Hou C; Huang S; Zhang Y; Wang C; Hou J
    Oncogene; 2021 Jun; 40(22):3885-3898. PubMed ID: 33972683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTO demethylates YAP mRNA promoting oral squamous cell carcinoma tumorigenesis.
    Li DQ; Huang CC; Zhang G; Zhou LL
    Neoplasma; 2022 Jan; 69(1):71-79. PubMed ID: 34779644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fat mass and obesity-associated protein regulates tumorigenesis of arecoline-promoted human oral carcinoma.
    Li X; Xie X; Gu Y; Zhang J; Song J; Cheng X; Gao Y; Ai Y
    Cancer Med; 2021 Sep; 10(18):6402-6415. PubMed ID: 34378866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterol regulatory element binding transcription factor 1 promotes proliferation and migration in head and neck squamous cell carcinoma.
    Tan M; Lin X; Chen H; Ye W; Yi J; Li C; Liu J; Su J
    PeerJ; 2023; 11():e15203. PubMed ID: 37090107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel positioning from obesity to cancer: FTO, an m
    Chen J; Du B
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.
    Zhang C; Cui Y
    Biol Chem; 2024 Mar; 405(3):217-228. PubMed ID: 37694982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.
    Wang A; Jin C; Wang Y; Yu J; Wang R; Tian X
    Mol Carcinog; 2023 Aug; 62(8):1228-1237. PubMed ID: 37306026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTO Sensitizes Oral Squamous Cell Carcinoma to Ferroptosis via Suppressing ACSL3 and GPX4.
    Wang Z; Li H; Cai H; Liang J; Jiang Y; Song F; Hou C; Hou J
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
    Wu J; Wang X; Li X
    Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3.
    Xie W; Shao Y; Bo Q; Li Z; Yu Q; Wang L; Wu G
    Mol Carcinog; 2024 May; 63(5):926-937. PubMed ID: 38380957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.